Rofecoxib safe in NSAID hypersensitivity

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 10, 2001, Pages 1017-1018

  Berges Gimeno, M P ^a   Camacho Garrido, E ^a   Garcia Rodriguez R M ^a   Alfaya, T ^a   Martin Garcia C ^a   Hinojosa, M ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

Angioedema; COX; COX 1; COX 2 inhibitors; NSAID intolerance; Rofecoxib; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; CLONIXIN; DICLOFENAC; DIPYRONE; IBUPROFEN; INDOMETACIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROPYPHENAZONE; ROFECOXIB;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; URTICARIA;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; LACTONES; MALE; SULFONES;

EID: 0034857046     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.00206.x     Document Type: Article

References (3)

1. Cox-2 inhibitors
2. Rofecoxib
3. Aspirin-induced asthma. Advances in pathogenesis and management